TY - JOUR
T1 - From operating room to pathology report
T2 - Delphi consensus on pathological assessment of peritoneal cytology and biopsies in staging laparoscopy for gastric cancer
AU - Quik, Judith S.E.
AU - de Neijs, Micha J.
AU - Grabsch, Heike I.
AU - Guchelaar, Niels A.D.
AU - Freund, Jan Erik
AU - Brosens, Lodewijk A.A.
AU - Oudijk, Lindsey
AU - van Velthuysen, Marie Louise F.
AU - Doukas, Michail
AU - Snaebjornsson, Petur
AU - Klooster, Astrid
AU - Doddema, Nienke
AU - van den Burg, Kay
AU - Wijnhoven, Bas P.L.
AU - van Sandick, Johanna W.
AU - Meijer, Sybren L.
AU - Kodach, Liudmila L.
AU - Kooreman, Loes
AU - Sefcovicova, Nina
AU - Riedl, Robert
AU - de Vries, Bart
AU - Diederen, Ilse
AU - Brosens, Lodewijk
AU - Muhlebner, Angelika
AU - Kats-Ugurlu, Gursah
AU - Knijn, Nikki
AU - van Tilburg, Arjan
AU - van der Post, Chella
AU - van der Horst, Michiel
AU - Crobach, Stijn
AU - van der Wel, Myrtle
AU - Grefte, Annemarie
AU - van Velthuysen, Marie Louise
AU - van der Klooster, Joy
AU - Ploeg, Dave
AU - Alkanat, Eylem
AU - Meijer, Sybren
AU - Peferoen, Laura
AU - Neefjes-Borst, Andra
AU - van Grieken, Nicole
AU - van den Berg, Jose
AU - Kodach, Liudmila
AU - Dutch Gastric Cancer Pathology Delphi Collaborators
N1 - Funding Information:
Liudmila L. Kodach, Johanna W. van Sandick and Judith S.E. Quik are supported by Dutch Cancer Foundation (KWF-18024). Heike I. Grabsch is supported by the National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre (grant number NIHR203331). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Publisher Copyright:
© The Author(s), under exclusive licence to The Author(s) 2026.
PY - 2026/10
Y1 - 2026/10
N2 - Background: Staging laparoscopy with peritoneal cytology and biopsies is recommended in selected patients with gastric cancer (GC), but practical guidance for assessment of peritoneal lavage/ascites and peritoneal biopsies is lacking. We aimed to develop consensus-based recommendations for handling, assessing and reporting of these specimens. Methods: A modified Delphi study was conducted among Dutch experts in GC (cyto)pathology. In round 1, sixty-two statements on clinical information, specimen requirements, initial assessment, ancillary testing, biomarker testing and reporting were rated on a 3-point scale (agree/neutral/disagree); consensus was predefined as = 80% agreement. Non-consensus statements were discussed in an online meeting, informed by comments and literature review, revised, and re-rated in Round 2 on a dichotomous agree/disagree scale, with consensus defined as = 70% agreement. Results: Thirty-one experts from university, general, and independent pathology practices participated. Consensus was achieved for 39 of 62 statements (63%) in Round 1 and for 58 of 62 statements (94%) after Round 2. Consensus was achieved on required clinical information from surgeons, specimen submission and handling, cytological and histological assessment, use of ancillary immunocytochemistry/immunohistochemistry, structured reporting categories, and approaches to biomarker testing on peritoneal biopsies. The study also resulted in structured reporting templates for peritoneal cytology and biopsies. Conclusion: This Delphi study achieved broad expert consensus on pathological assessment of peritoneal fluid and biopsies obtained during staging laparoscopy in GC patients. The resulting recommendations and structured reporting templates provide a practical framework to harmonise specimen handling, evaluation and reporting, thereby promoting greater standardisation and consistency in GC staging.
AB - Background: Staging laparoscopy with peritoneal cytology and biopsies is recommended in selected patients with gastric cancer (GC), but practical guidance for assessment of peritoneal lavage/ascites and peritoneal biopsies is lacking. We aimed to develop consensus-based recommendations for handling, assessing and reporting of these specimens. Methods: A modified Delphi study was conducted among Dutch experts in GC (cyto)pathology. In round 1, sixty-two statements on clinical information, specimen requirements, initial assessment, ancillary testing, biomarker testing and reporting were rated on a 3-point scale (agree/neutral/disagree); consensus was predefined as = 80% agreement. Non-consensus statements were discussed in an online meeting, informed by comments and literature review, revised, and re-rated in Round 2 on a dichotomous agree/disagree scale, with consensus defined as = 70% agreement. Results: Thirty-one experts from university, general, and independent pathology practices participated. Consensus was achieved for 39 of 62 statements (63%) in Round 1 and for 58 of 62 statements (94%) after Round 2. Consensus was achieved on required clinical information from surgeons, specimen submission and handling, cytological and histological assessment, use of ancillary immunocytochemistry/immunohistochemistry, structured reporting categories, and approaches to biomarker testing on peritoneal biopsies. The study also resulted in structured reporting templates for peritoneal cytology and biopsies. Conclusion: This Delphi study achieved broad expert consensus on pathological assessment of peritoneal fluid and biopsies obtained during staging laparoscopy in GC patients. The resulting recommendations and structured reporting templates provide a practical framework to harmonise specimen handling, evaluation and reporting, thereby promoting greater standardisation and consistency in GC staging.
KW - Cytodiagnosis
KW - Delphi consensus
KW - Gastric cancer
KW - Laparoscopy
KW - Peritoneum
U2 - 10.1007/s10120-026-01803-1
DO - 10.1007/s10120-026-01803-1
M3 - Article
SN - 1436-3291
JO - Gastric Cancer
JF - Gastric Cancer
ER -